2021 Q4 Form 10-Q Financial Statement

#000185173421000076 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $6.483M $5.219M $3.894M
YoY Change 53.26% 34.03% -30.34%
Cost Of Revenue $3.376M $2.310M $1.666M
YoY Change 59.47% 38.66% -34.02%
Gross Profit $3.107M $2.909M $2.228M
YoY Change 47.04% 30.57% -27.31%
Gross Profit Margin 47.93% 55.74% 57.22%
Selling, General & Admin $2.513M $2.526M $2.408M
YoY Change -11.73% 4.9% -43.41%
% of Gross Profit 80.88% 86.83% 108.08%
Research & Development $10.00K $5.000K $741.0K
YoY Change -99.33%
% of Gross Profit 0.32% 0.17% 33.26%
Depreciation & Amortization $55.00K $53.00K $48.00K
YoY Change 10.0% 10.42% 100.0%
% of Gross Profit 1.77% 1.82% 2.15%
Operating Expenses $2.523M $4.841M $4.815M
YoY Change -11.57% 0.54% 13.16%
Operating Profit $584.0K $378.0K -$921.0K
YoY Change -178.92% -141.04% -22.61%
Interest Expense $1.643M $2.000K $29.00K
YoY Change -66.71% -93.1% -98.94%
% of Operating Profit 281.34% 0.53%
Other Income/Expense, Net $4.000K $2.729M -$5.903M
YoY Change 100.0% -146.23%
Pretax Income $2.416M $3.107M -$6.824M
YoY Change -42.44% -145.53% -538.28%
Income Tax $342.0K $0.00
% Of Pretax Income 14.16% 0.0%
Net Earnings $2.074M $3.107M -$6.824M
YoY Change -50.58% -145.53% -538.28%
Net Earnings / Revenue 31.99% 59.53% -175.24%
Basic Earnings Per Share $0.02 -$0.04
Diluted Earnings Per Share $9.439K $0.00 -$0.04
COMMON SHARES
Basic Shares Outstanding 210.4M 206.3M 189.9M
Diluted Shares Outstanding 238.6M 189.9M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $866.0K $1.270M $1.209M
YoY Change -39.1% 5.05% -70.98%
Cash & Equivalents $866.0K $1.270M $1.209M
Short-Term Investments
Other Short-Term Assets $755.0K $1.161M $664.0K
YoY Change 67.78% 74.85% -19.02%
Inventory $5.005M $2.305M $1.764M
Prepaid Expenses
Receivables $1.368M $931.0K $1.358M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.994M $5.667M $4.995M
YoY Change 69.26% 13.45% -42.24%
LONG-TERM ASSETS
Property, Plant & Equipment $431.0K $449.0K $1.876M
YoY Change -18.83% -76.07% 76.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $68.00K $67.00K $71.00K
YoY Change -4.23% -5.63% 4.41%
Total Long-Term Assets $1.254M $1.385M $1.947M
YoY Change -30.41% -28.86% 72.0%
TOTAL ASSETS
Total Short-Term Assets $7.994M $5.667M $4.995M
Total Long-Term Assets $1.254M $1.385M $1.947M
Total Assets $9.248M $7.052M $6.942M
YoY Change 41.73% 1.58% -29.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.476M $683.0K $2.466M
YoY Change 293.64% -72.3% 27.38%
Accrued Expenses $1.579M $1.715M $450.0K
YoY Change 246.27% 281.11% 75.1%
Deferred Revenue $238.0K $221.0K
YoY Change -11.19%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $1.400M
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $5.534M $5.162M $15.59M
YoY Change -48.49% -66.9% 116.94%
LONG-TERM LIABILITIES
Long-Term Debt $150.0K $334.0K $1.016M
YoY Change -85.24% -67.13%
Other Long-Term Liabilities $433.0K $488.0K $880.0K
YoY Change -43.18% -44.55% 93.83%
Total Long-Term Liabilities $583.0K $822.0K $1.896M
YoY Change -67.21% -56.65% 317.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.534M $5.162M $15.59M
Total Long-Term Liabilities $583.0K $822.0K $1.896M
Total Liabilities $6.117M $5.984M $17.49M
YoY Change -51.15% -65.79% 128.87%
SHAREHOLDERS EQUITY
Retained Earnings -$4.855M -$6.929M
YoY Change -49.76%
Common Stock $211.0K $210.0K
YoY Change 11.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.131M $1.068M -$10.55M
YoY Change
Total Liabilities & Shareholders Equity $9.248M $7.052M $6.942M
YoY Change 41.73% 1.58% -29.02%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $2.074M $3.107M -$6.824M
YoY Change -50.58% -145.53% -538.28%
Depreciation, Depletion And Amortization $55.00K $53.00K $48.00K
YoY Change 10.0% 10.42% 100.0%
Cash From Operating Activities -$367.0K -$655.0K -$864.0K
YoY Change -260.26% -24.19% 12.06%
INVESTING ACTIVITIES
Capital Expenditures -$37.00K -$33.00K -$41.00K
YoY Change 131.25% -19.51% -77.6%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$37.00K -$33.00K -$41.00K
YoY Change 131.25% -19.51% -77.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -3.000K 650.0K
YoY Change -100.46%
NET CHANGE
Cash From Operating Activities -367.0K -655.0K -864.0K
Cash From Investing Activities -37.00K -33.00K -41.00K
Cash From Financing Activities 0.000 -3.000K 650.0K
Net Change In Cash -404.0K -691.0K -255.0K
YoY Change -289.67% 170.98% -73.27%
FREE CASH FLOW
Cash From Operating Activities -$367.0K -$655.0K -$864.0K
Capital Expenditures -$37.00K -$33.00K -$41.00K
Free Cash Flow -$330.0K -$622.0K -$823.0K
YoY Change -234.69% -24.42% 39.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
392000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
456000 USD
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
210427674
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1800000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1800000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
210427674
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
210427674
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
189907526
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
189907526
CY2019Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021Q3 us-gaap Cash
Cash
1270000 USD
CY2020Q4 us-gaap Cash
Cash
1422000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
931000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1258000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
2305000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1593000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1161000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
450000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
5667000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
4723000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
449000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
531000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
869000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1200000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
67000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
71000 USD
CY2021Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1385000 USD
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1802000 USD
CY2021Q3 us-gaap Assets
Assets
7052000 USD
CY2020Q4 us-gaap Assets
Assets
6525000 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2006000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2525000 USD
CY2021Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2543000 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4444000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
5984000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
12521000 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
210000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
190000 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1400000 USD
CY2021Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 USD
CY2020Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
1650000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
221000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
268000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5162000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10743000 USD
CY2021Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
334000 USD
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1016000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
488000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
762000 USD
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
822000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1778000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7787000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3477000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6929000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9663000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1068000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5996000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7052000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6525000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5219000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3894000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
15013000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12462000 USD
CY2021Q3 chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
2310000 USD
CY2020Q3 chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
1666000 USD
chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
7047000 USD
chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
5361000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2084000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2073000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6759000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8500000 USD
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
442000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
335000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1212000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1259000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
741000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3372000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
4841000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
4815000 USD
us-gaap Operating Expenses
OperatingExpenses
15032000 USD
us-gaap Operating Expenses
OperatingExpenses
18492000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
378000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-921000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-19000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6030000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
2000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
29000 USD
us-gaap Interest Expense
InterestExpense
33000 USD
us-gaap Interest Expense
InterestExpense
105000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2729000 USD
CY2020Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-5874000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1901000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-5264000 USD
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
875000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q3 us-gaap Other Income
OtherIncome
2000 USD
CY2020Q3 us-gaap Other Income
OtherIncome
0 USD
us-gaap Other Income
OtherIncome
10000 USD
us-gaap Other Income
OtherIncome
15000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2729000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5903000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2753000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5354000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
3107000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-6824000 USD
us-gaap Net Income Loss
NetIncomeLoss
2734000 USD
us-gaap Net Income Loss
NetIncomeLoss
-11384000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
206321051
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189907527
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
201206587
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189823828
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
238550798
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189907527
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
243674985
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189823828
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-2075000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
0 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
3000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
39000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
3107000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1068000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-4105000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
381000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-6824000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-10548000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5996000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3000000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
0 USD
chuc Stock Issued During Period Value Dividend Payments
StockIssuedDuringPeriodValueDividendPayments
770000 USD
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
3000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
563000 USD
us-gaap Net Income Loss
NetIncomeLoss
2734000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1068000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-547000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
0 USD
chuc Adjustments To Additional Paid In Capital Reclassification Of Liabilities To Equity
AdjustmentsToAdditionalPaidInCapitalReclassificationOfLiabilitiesToEquity
1638000 USD
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
1650000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1395000 USD
us-gaap Net Income Loss
NetIncomeLoss
-11384000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-10548000 USD
us-gaap Net Income Loss
NetIncomeLoss
2734000 USD
us-gaap Net Income Loss
NetIncomeLoss
-11384000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
93000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
480000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
155000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
131000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1901000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-5264000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
331000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
312000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
563000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2717000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
875000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 USD
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-1634000 USD
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
8904000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-234000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
920000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
712000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
248000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
711000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-65000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-4000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-0 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-510000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
266000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-47000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
129000 USD
chuc Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-338000 USD
chuc Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-314000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-980000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3502000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
73000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
153000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-73000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-153000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3000000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
184000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2416000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1400000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
883000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
-0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
901000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2416000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-152000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1239000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1422000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2448000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1270000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1209000 USD
us-gaap Interest Paid Net
InterestPaidNet
150000 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Operating Income Loss
OperatingIncomeLoss
-19000 USD
chuc Dividends Accrual
DividendsAccrual
3000 USD
chuc Dividends Accrual
DividendsAccrual
1650000 USD
chuc Reclassification Of Liability Awards To Equity
ReclassificationOfLiabilityAwardsToEquity
0 USD
chuc Reclassification Of Liability Awards To Equity
ReclassificationOfLiabilityAwardsToEquity
1638000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
14000 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
17000 USD
us-gaap Stock Issued1
StockIssued1
770000 USD
us-gaap Stock Issued1
StockIssued1
0 USD
us-gaap Net Income Loss
NetIncomeLoss
2734000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1068000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-980000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2753000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1901000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3000000 USD
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3517000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Use of Estimates</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expense during the reporting periods. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Reclassifications</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">Prior period financial statement amounts are reclassified as necessary to conform to the current period presentation. These prior period reclassifications did <em style="font: inherit;">not</em> affect the Company’s net income (loss), earnings (loss) per share, stockholders’ equity (deficit) or working capital.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4444000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-1901000 USD
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2543000 USD
CY2019Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
27500000 USD
CY2019Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.44313
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1067000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
994000 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
618000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
463000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
449000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
531000 USD
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
53000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
48000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
155000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
131000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
683000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
629000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1193000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1420000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
130000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
476000 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2006000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2525000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2021Q3 chuc Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
334000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
334000 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3107000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6824000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2734000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11384000 USD
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2729000 USD
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1901000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
378000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6824000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
833000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11384000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
206321051
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189907527
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
201206587
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189823828
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1351628
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2021Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2020Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
8887023
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2021Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
32229747
CY2020Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
32229747
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
238550798
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189907527
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
243674985
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189823828
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37682000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
103942000
CY2021Q2 chuc Share Exchange Value Per Share
ShareExchangeValuePerShare
0.44313
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Share Price
SharePrice
0.44313
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3000000.0 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7503000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.54
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
80000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.44
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7583000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.54
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M12D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
5520000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.57
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y7M6D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 USD
CY2019Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
9000000.0
CY2019Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.32
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2900000 USD
CY2019Q2 chuc Common Stock Awards Unvested
CommonStockAwardsUnvested
7100000
CY2019Q2 chuc Common Stock Awards Fair Value Per Share
CommonStockAwardsFairValuePerShare
0.32
CY2021Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
1500000
CY2021Q2 chuc Shares Restricted Stock Award Subject To Annual Forfeiture
SharesRestrictedStockAwardSubjectToAnnualForfeiture
750000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
39000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
563000 USD
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
139000 USD
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
149000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
427000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
448000 USD
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
0 USD
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
0 USD
us-gaap Variable Lease Cost
VariableLeaseCost
0 USD
us-gaap Variable Lease Cost
VariableLeaseCost
0 USD
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
139000 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
149000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
427000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
448000 USD
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 USD
CY2020Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 USD
CY2021Q3 us-gaap Lease Cost
LeaseCost
139000 USD
CY2020Q3 us-gaap Lease Cost
LeaseCost
149000 USD
us-gaap Lease Cost
LeaseCost
427000 USD
us-gaap Lease Cost
LeaseCost
448000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
331000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
312000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M4D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.120 pure
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.120 pure
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
143000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
399000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
275000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
206000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1023000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
143000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
880000 USD

Files In Submission

Name View Source Status
0001851734-21-000076-index-headers.html Edgar Link pending
0001851734-21-000076-index.html Edgar Link pending
0001851734-21-000076.txt Edgar Link pending
0001851734-21-000076-xbrl.zip Edgar Link pending
chuc-20210930.xsd Edgar Link pending
chuc-20210930_cal.xml Edgar Link unprocessable
chuc-20210930_def.xml Edgar Link unprocessable
chuc-20210930_lab.xml Edgar Link unprocessable
chuc-20210930_pre.xml Edgar Link unprocessable
chuc20210930_10q.htm Edgar Link pending
chuc20210930_10q_htm.xml Edgar Link completed
ex_304270.htm Edgar Link pending
ex_304271.htm Edgar Link pending
ex_304272.htm Edgar Link pending
ex_304273.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending